KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash from Financing Activities (2016 - 2025)

Tenet Healthcare's Cash from Financing Activities history spans 17 years, with the latest figure at -$434.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 16.67% year-over-year to -$434.0 million; the TTM value through Dec 2025 reached -$2.4 billion, up 34.84%, while the annual FY2025 figure was -$2.4 billion, 34.84% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$434.0 million at Tenet Healthcare, down from -$323.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.2 billion in Q4 2021 and bottomed at -$2.7 billion in Q1 2024.
  • The 5-year median for Cash from Financing Activities is -$347.5 million (2024), against an average of -$491.9 million.
  • The largest annual shift saw Cash from Financing Activities soared 1356.12% in 2021 before it plummeted 943.53% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.2 billion in 2021, then crashed by 137.77% to -$465.0 million in 2022, then soared by 31.83% to -$317.0 million in 2023, then fell by 17.35% to -$372.0 million in 2024, then decreased by 16.67% to -$434.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Cash from Financing Activities are -$434.0 million (Q4 2025), -$323.0 million (Q3 2025), and -$996.0 million (Q2 2025).